![फेड की आक्रामक नीति से डॉलर में उछाल; मुद्रास्फीति के प्रमुख आंकड़े आने वाले हैं](https://i-invdn-com.investing.com/news/LYNXMPEE0I024_S.jpg)
कृपया अन्य खोज का प्रयास करें
InVivo Therapeutics Holdings Corp. operates as a research and clinical-stage biomaterials and biotechnology company in the United States. The company engages in developing and commercializing biopolymer scaffolding devices for the treatment of spinal cord injuries (SCI). It is developing a Neuro-Spinal Scaffold implant comprise of biocompatible and bioresorbable polymers, which includes Poly lactic-co-glycolic acid, a polymer which is widely used in resorbable sutures and provides the biocompatible support for Neuro-Spinal Scaffold implant; and Poly-L-Lysine, a positively charged polymer used to coat surfaces to promote cellular attachment. The company was incorporated in 2003 and is headquartered in Cambridge, Massachusetts.
नाम | आयु | पहले | शीर्षक |
---|---|---|---|
V. Reggie Edgerton | - | - | Member of Scientific Advisory Board |
Richard M. Toselli | 63 | 2017 | President, CEO, Chief Medical Officer & Director |
Richard J. Roberts | 78 | 2007 | Independent Director & Member of Scientific Advisory Board |
Christina Takoudes Morrison | 55 | 2016 | Independent Director |
Robert J. Rosenthal | 65 | 2019 | Independent Director |
Robert S. Langer | 74 | 2005 | Co-Founder & Member of Scientific Advisory Board |
C. Ann Merrifield | 72 | 2014 | Independent Chair of the Board |
James Guest | - | 2015 | Member of Scientific Advisory Board |
क्या आप सच में %USER_NAME% को ब्लॉक करना चाहते हैं?
ऐसा करके, आप और %USER_NAME% नहीं देख पाएंगे किसी अन्य के Investing.com की पोस्ट में से कोई भी।
%USER_NAME% को सफलतापूर्वक आपकी ब्लॉक सूची में जोड़ लिया गया है
क्योंकि आपने इस व्यक्ति को अनब्लॉक कर दिया है, आपको ब्लॉक को रिन्यू करने से पहले 48 घंटे प्रतीक्षा करनी होगी।
मुझे लगता है कि यह टिपण्णी:
धन्यवाद!
आपकी रिपोर्ट समीक्षा के लिए हमारे मॉडरेटर को भेजी गई है